Suncorp Group Limited Announced the Resignation of its CEO and MD, Michael Cameron

Suncorp Group Limited (ASX: SUN) is one of Australia and New Zealand’s leading financial services organisations. The company today has announced the resignation of its CEO and Managing Director Mr. Michael Cameron who had Joined Suncorp in 2006.

Mr. Michael Cameron served almost four years as the CEO and Managing Director and seven years as a Board member, making a considerable contribution to the company.

According to the company’s Chairman Christine McLoughlin, Michael Cameron resignation will provide the opportunity for Suncorp Group to enhance its performance in a highly competitive and challenging external environment as it seeks to strengthen its core businesses by focusing on its customers, products and brands.

In order to ensure a smooth transition, Mr. Cameron is going to remain employed in an advisory capacity until 9 August 2019. In the interim, the company’s Board of directors has appointed highly experienced Group CFO Mr. Steve Johnston as acting CEO of the company.

Mr. Johnston is having a deep understating about Suncorp’s core insurance and banking businesses and he is very well placed to lead Suncorp and build on the Group’s multi-channel capability, said Ms. McLoughlin.

Currently, the Board is searching to identify external domestic and international candidates who will also be considered in the selection process. It is expected that the Board will announce the new CEO in the latter part of the year.

Despite operating in challenging environment, Suncorp has confirmed that its FY19 cash earnings are in line with market expectations. The company is expected to deliver its full year 2019 result on 7 August 2019.

For the half-year ended 31 December 2018, the company reported a net profit after tax of $250 as compared to $452 million in the previous corresponding period (pcp). The net profit was 44.7% lower than the pcp, mainly attributable to –

  • Write down of Life goodwill of $145m
  • Investment market impact of $140 million
  • Natural hazard increase of $167million
  • Reserve release increase of $47 million
  • Doubling of regulatory project costs to $39 million
  • Prior period included $36 million accelerated investment in strategic programs

H1 FY19 Results (Source: Company Reports)

The company’s half-year results reflected solid Group top-line growth of 3.2% and besides that, during the period, the company witnessed an improvement in Insurance (Australia)’s underlying margins.

As at 31 December 2018, the company had net assets of $13,624 million which was lesser than $13,973 million at 30 June 2018, driven by the payment of the 2018 final and interim dividend.

In the past six months, the share price of the company increased by 4.34% as on 24 May 2019. At the time of writing, i.e., on 27 May 2019 AEST 3:04 PM, the stock of the company was trading at a price of A$13.610, down by 2.086% during the day’s trade with the market capitalisation of ~A$18.05 Bn. The stock is trading at a PE multiple of 20.940x.


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report